The use of specific neuroimaging techniques, such as fluorodeoxyglucose positron emission tomography (FDG-PET) may be helpful (85), as is the visualization of early amyloid and tau aggregates also assessed through PET. The gene discussed is MAPT; the disease is amyloidosis.